{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:23:09Z","timestamp":1793190189663,"version":"4.5.0"},"reference-count":129,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2023,12,12]]},"DOI":"10.1080\/07853890.2022.2157477","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:54:33Z","timestamp":1672242873000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":187,"title":["Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists"],"prefix":"10.1080","volume":"55","author":[{"given":"John","family":"Sheppard","sequence":"first","affiliation":[{"name":"Virginia Eye Consultants, Eyecare Partners, Norfolk, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgitte","family":"Shen Lee","sequence":"additional","affiliation":[{"name":"Vision Optique, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Periman","sequence":"additional","affiliation":[{"name":"Periman Eye Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.006"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.011"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70076-9"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.003"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0270"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000464"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2021.05.006"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00462-7"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70043-5"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19419"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.10.015"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.001"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-020-00308-z"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.10.023"},{"issue":"19","key":"e_1_3_5_18_1","first-page":"11","article-title":"Varenicline nasal spray approved as a treatment for dry eye disease","volume":"46","author":"Guttman Krader C.","year":"2021","unstructured":"Guttman Krader C. Varenicline nasal spray approved as a treatment for dry eye disease. Ophthalmology Times. 2021;46(19):11\u201312.","journal-title":"Ophthalmology Times"},{"key":"e_1_3_5_19_1","unstructured":"Oyster Point Pharma. Tyrvaya (varenicline solution) nasal spray full prescribing information. 2021."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70104-0"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.07.011"},{"key":"e_1_3_5_22_1","unstructured":"Novartis Pharmaceuticals Corporation. Xiidra (lifitegrast ophthalmic solution) full prescribing information. 2020."},{"key":"e_1_3_5_23_1","unstructured":"Allergan Inc. Restasis (cyclosporine ophthalmic emulsion) 0.05% full prescribing information. 2017."},{"key":"e_1_3_5_24_1","unstructured":"Sun Pharmaceutical Industries Inc. Cequa (cyclosporine ophthalmic solution) 0.09% full prescribing information. 2018."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.062"},{"key":"e_1_3_5_26_1","volume-title":"Azithromycin","author":"Sandman Z","year":"2022","unstructured":"Sandman Z, Iqbal OA. Azithromycin. Treasure Island, FL: StatPearls Publishing; 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557766\/?report=printable"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/18.6.311"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-6-18"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1649"},{"key":"e_1_3_5_30_1","volume-title":"Minocycline","author":"Nazarian S","year":"2022","unstructured":"Nazarian S, Akhondi H. Minocycline. Treasure Island, FL: StatPearls Publishing; 2022, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554519\/?report=printable"},{"key":"e_1_3_5_31_1","volume-title":"Doxycycline hyclate","author":"Patel RS","year":"2022","unstructured":"Patel RS, Parmar M. Doxycycline hyclate. Treasure Island, FL: StatPearls Publishing; 2022, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555888\/?report=printable"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922814528032"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.099085"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601186"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.e478"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2007.10.007"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21426"},{"issue":"1","key":"e_1_3_5_38_1","first-page":"CD004227","article-title":"Antioxidants for preventing pre-eclampsia","volume":"2008","author":"Rumbold A","year":"2008","unstructured":"Rumbold A, Duley L, Crowther CA, et\u00a0al. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008;2008(1):CD004227.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.31080\/ASOP.2020.03.0177"},{"key":"e_1_3_5_40_1","article-title":"Devices for treating the meibomian glands","author":"Kent C.","unstructured":"Kent C. Devices for treating the meibomian glands. Rev Ophthalmol. https:\/\/www.reviewofophthalmology.com\/article\/devices-for-treating-the-meibomian-glands","journal-title":"Rev Ophthalmol"},{"key":"e_1_3_5_41_1","unstructured":"Conforming punctum plug granted FDA approval. Ocular Surgery News. 2022. https:\/\/www.healio.com\/news\/ophthalmology\/20120331\/conforming-punctum-plug-granted-fda-approval"},{"key":"e_1_3_5_42_1","unstructured":"FDA approves Lacrivera punctum plug. Primary Care Optometry News. 2022. https:\/\/www.healio.com\/news\/optometry\/20141211\/fda-approves-lacrivera-punctum-plug#:\u223c:text=Lacrivera%20received%20U.S.%20Food%20and sterile%2C%20disposable%20inserter%2Fdilator"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2018.10.003"},{"key":"e_1_3_5_44_1","unstructured":"Villani E Nucci P. Pediatric dry eye. Am Acad Ophthalmol. https:\/\/www.aao.org\/disease-review\/pediatric-dry-eye."},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S109663"},{"key":"e_1_3_5_46_1","unstructured":"501(k) summary: Lipiflow\u00ae Thermal Pulsation System. 2016."},{"key":"e_1_3_5_47_1","unstructured":"Summary of important safety information for the Lipiflow\u00ae Thermal Pulsation System. Johnson & Johnson Vision. 2022. https:\/\/www.jnjvisionpro.com\/important-safety-information#tab-2."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2011.613480"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.08.021"},{"key":"e_1_3_5_50_1","unstructured":"D H. FDA approves IPL device to manage dry eye disease. 2022. https:\/\/www.ophthalmologytimes.com\/view\/fda-approves-ipl-device-to-manage-dry-eye-disease"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2017.1406525"},{"issue":"3","key":"e_1_3_5_52_1","first-page":"CD013559","article-title":"Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction","volume":"3","author":"Cote S","year":"2020","unstructured":"Cote S, Zhang AC, Ahmadzai V, et\u00a0al. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev. 2020;3(3):CD013559.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2021.1878866"},{"issue":"8","key":"e_1_3_5_54_1","first-page":"2236","article-title":"The effects of a red light technology on dry eye due to meibomian gland dysfunction","volume":"58","author":"Toyos R.","year":"2017","unstructured":"Toyos R. The effects of a red light technology on dry eye due to meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2017;58(8):2236.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"e_1_3_5_55_1","first-page":"29","article-title":"Lid hygiene versus lid hygiene plus microblepharoexfoliation for the treatment of demodex folliculorum blepharitis","volume":"3","author":"Choi MB","year":"2020","unstructured":"Choi MB, Stein R. Lid hygiene versus lid hygiene plus microblepharoexfoliation for the treatment of demodex folliculorum blepharitis. Acta Sci Ophthalmol. 2020;3(9):29\u201335.","journal-title":"Acta Sci Ophthalmol"},{"issue":"1","key":"e_1_3_5_56_1","article-title":"A review of meibomian gland dysfuntion as presented at dry eye university","volume":"3","author":"Bowden FW.","year":"2020","unstructured":"Bowden FW. A review of meibomian gland dysfuntion as presented at dry eye university. JDED. 2020;3(SP1).","journal-title":"JDED"},{"key":"e_1_3_5_57_1","doi-asserted-by":"crossref","unstructured":"Epstein IJ Rosenberg E Stuber R et al. Double-masked and unmasked prospective study of terpinen-4-ol lid scrubs with microblepharoexfoliation for the treatment of demodex blepharitis. Cornea. 2020;39(4):408\u2013416.","DOI":"10.1097\/ICO.0000000000002243"},{"key":"e_1_3_5_58_1","unstructured":"How BlephEx\u00ae Works. BlephEx.com. 2022. https:\/\/blephex.com\/patients\/index.php\/how-does-blephex-work.html"},{"key":"e_1_3_5_59_1","first-page":"30","article-title":"Reviewing in-office dry eye disease treatments: a look at what is available, and their specific benefits","volume":"25","author":"Loh J.","year":"2021","unstructured":"Loh J. Reviewing in-office dry eye disease treatments: a look at what is available, and their specific benefits. Corneal Physician. 2021;25:30\u201333.","journal-title":"Corneal Physician"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000208822.70732.25"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e3182960ff9"},{"key":"e_1_3_5_62_1","unstructured":"Blephasteam\u00ae. Thea. 2022. https:\/\/www.thea-pharmaceuticals.co.uk\/products\/blephasteam"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15052"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997g"},{"key":"e_1_3_5_65_1","unstructured":"Digital Heat Corporation heated eye pad ophthalmic warmer medical device identification. Food and Drug Administration. 2022. https:\/\/fda.report\/GUDID\/B172HEP10"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3180dc99d5"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.22374\/jded.v3i1.25"},{"key":"e_1_3_5_68_1","unstructured":"US Food and Drug Administration. Marketing approval for iTear\u00ae 100 Neurostimulator\u2122. 2022. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K213623.pdf"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.12.23"},{"key":"e_1_3_5_70_1","unstructured":"Inc. OO. iTear\u00ae 100 patient brochure. 2022. https:\/\/olympicophthalmics.com\/itear-100\/."},{"key":"e_1_3_5_71_1","unstructured":"Inc. OO. Patient guide for the iTear\u00ae 100 Neurostimulator\u2122. 2022. https:\/\/olympicophthalmics.com\/itear-100\/"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S228838"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.004"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815c5f4f"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0881-9"},{"issue":"1","key":"e_1_3_5_76_1","first-page":"1026","article-title":"Comparative in\u00a0vitro toxicity of artificial tears","volume":"3","author":"Zheng L","year":"2015","unstructured":"Zheng L, Yu MD, Ta C. Comparative in\u00a0vitro toxicity of artificial tears. JSM Ophthalmol. 2015;3(1):1026.","journal-title":"JSM Ophthalmol"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000495"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2019.55.3.156"},{"key":"e_1_3_5_79_1","unstructured":"Latisse\u00ae (bimatoprost opthalmic solution) 0.03%. Full prescribing information. Allergan Inc. 2012."},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01517-x"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2003.00634.x"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.12.1359"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000356"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001382"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(11)70034-9"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.04.010"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25572"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2010.519850"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S81515"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.01993.x"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0860"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/848659"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S117261"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307369"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000257"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/09286580600745969"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/543835"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047081"},{"issue":"11","key":"e_1_3_5_99_1","first-page":"CD008872","article-title":"Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)","author":"Colebatch AN","year":"2011","unstructured":"Colebatch AN, Marks JL, Edwards CJ. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. 2011;11:CD008872.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39480"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/285851"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1403584"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000393"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000211"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2016.06.009"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14029"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199107000-00002"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000656"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181a16858"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318183a396"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2018.06.005"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.17.2114"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0212"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302705"},{"issue":"2","key":"e_1_3_5_115_1","first-page":"51","article-title":"Dry eye syndrome in menopause and perimenopausal age group","volume":"8","author":"Peck T","year":"2017","unstructured":"Peck T, Olsakovsky L, Aggarwal S. Dry eye syndrome in menopause and perimenopausal age group. J Midlife Health. 2017;8(2):51\u201354.","journal-title":"J Midlife Health"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt038"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13093"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.01.026"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001476"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1277-9"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00934.x"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.06.030"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2007.50"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181e2eac5"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000042"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2015.01.007"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.96"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S198349"},{"issue":"4","key":"e_1_3_5_129_1","first-page":"531","article-title":"Electronic device screen time and meibomian gland morphology in children","volume":"16","author":"Kocami\u015f \u00d6","unstructured":"Kocami\u015f \u00d6, Temel E, A\u015fikgarip N, et\u00a0al. Electronic device screen time and meibomian gland morphology in children. J Ophthalmic Vis Res.;16(4):531\u2013537.","journal-title":"J Ophthalmic Vis Res"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0364-4"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2022.2157477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T14:35:32Z","timestamp":1705415732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2022.2157477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,12]]}},"alternative-id":["10.1080\/07853890.2022.2157477"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2022.2157477","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}